[1]
2026. Impact of local treatment on survival outcomes in patients with metastatic lung cancer with oligoprogression undergoing immunotherapy. Swiss Medical Weekly. 156, 4 (Apr. 2026), 4790. DOI:https://doi.org/10.57187/4790.